WuXi Biologics Cayman Inc. (药明生物技术有限公司) is based in Hong Kong SAR, China, with the head office in Wuxi. The enterprise operates in the Research and Development in the Physical, Engineering, and Life Sciences industry. It was first established on April 20, 2026. WuXi Biologics Cayman Inc. (药明生物技术有限公司) currently employs 13,252 (2025) people. From the latest financial highlights, WuXi Biologics Cayman Inc. (药明生物技术有限公司) reported a net sales revenue increase of 16.24% in 2025. There was a total growth of 14.6% in WuXi Biologics Cayman Inc. (药明生物技术有限公司)’s total assets over the same period. In 2025, WuXi Biologics Cayman Inc. (药明生物技术有限公司)’s net profit margin increased by 5.18%.
Headquarters
No. 88 Meiliang West Road, Mashan
Wuxi; Jiangsu;
Contact Details: Purchase the WuXi Biologics Cayman Inc. (药明生物技术有限公司) report to view the information.
Website: http://www.wuxibiologics.com.cn
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service